How current barriers along the roadway between biomarker testing and drug prescribing can affect decision-making for precision medicines. The value of precision medicine, which relies on identifying ...
The study is vanishingly small, involving 11 more physicians than the 21 listed authors of the paper, so let’s not put a whole lot of credence in the findings but think a bit more about underlying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback